Johnson & Johnson (NYSE:JNJ) is on the losing end of a jury verdict in California in a court case involving a woman who claimed that the company's baby powder caused her ovarian cancer. The company has been ordered to pay $417M to the plaintiff, a ruling it plans to appeal. Investors appear unconcerned. Shares were up 1% in the session.
READ FULL ARTICLE HERE
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that Matthew S. Rheingold has been elevated from
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that partners Thomas J. Snyder and Matheu D. Nunn
Mark H. Anania, a partner at McCarter & English, LLP, has been named President of the New Jersey Intellectual Property Law Association
Cohen Seglias Pallas Greenhall & Furman PC is pleased to announce that Anthony H. Chwastyk has joined the
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
